These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3142481)

  • 1. Modulation of prostacyclin/thromboxane formation by molsidomine during platelet-endothelial cell interactions.
    Bordet JC; Lagarde M
    Biochem Pharmacol; 1988 Oct; 37(20):3911-4. PubMed ID: 3142481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of SIN-1 on thromboxane and prostacyclin formation in platelets and endothelial cells.
    Lagarde M; Bordet JC; Croset M
    J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S95-7. PubMed ID: 2484709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-relationships between vascular thromboxane and prostacyclin synthesis.
    James MJ; Walsh JA
    Prostaglandins Leukot Essent Fatty Acids; 1988 Feb; 31(2):91-5. PubMed ID: 3128801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between cyclic AMP and thromboxane formation in platelet-endothelial cell interactions.
    Lagarde M; Felisi O; Boukhchache D; Sicard B; Dechavanne M
    Thromb Res; 1984 Jul; 35(2):141-7. PubMed ID: 6089369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of molsidomine, an anti-anginal drug, on arachidonic acid metabolism in human platelets.
    Croset M; Lagarde M
    Biomed Biochim Acta; 1984; 43(8-9):S354-7. PubMed ID: 6440549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotine inhibits vascular prostacyclin but not platelet thromboxane formation.
    Wennmalm A; Alster P
    Gen Pharmacol; 1983; 14(1):189-91. PubMed ID: 6402415
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet and blood vessel arachidonate metabolism and interactions.
    Needleman P; Wyche A; Raz A
    J Clin Invest; 1979 Feb; 63(2):345-9. PubMed ID: 372240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells.
    Schafer AI; Crawford DD; Gimbrone MA
    J Clin Invest; 1984 Apr; 73(4):1105-12. PubMed ID: 6423665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cellular mechanism of action of molsidomine. Bioinduction of prostacyclin].
    Poincelot B; Russo-Marie F
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):535-7. PubMed ID: 6421223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.
    Block HU; Förster W; Heinroth I
    Arzneimittelforschung; 1982; 32(3):189-94. PubMed ID: 6896278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet responsiveness and biosynthesis of thromboxane and prostacyclin in response to in vitro cocaine treatment.
    Togna G; Tempesta E; Togna AR; Dolci N; Cebo B; Caprino L
    Haemostasis; 1985; 15(2):100-7. PubMed ID: 3924789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.
    Marcus AJ; Weksler BB; Jaffe EA; Broekman MJ
    J Clin Invest; 1980 Nov; 66(5):979-86. PubMed ID: 6776148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of labetalol on the arachidonic acid metabolism in human blood platelets, and in lung and aorta of the rat.
    Srivastava KC; Awasthi KK
    Prostaglandins Leukot Med; 1983 Sep; 12(1):1-9. PubMed ID: 6356152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine endothelial cells in culture produce thromboxane as well as prostacyclin.
    Ingerman-Wojenski C; Silver MJ; Smith JB; Macarak E
    J Clin Invest; 1981 May; 67(5):1292-6. PubMed ID: 7014633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet cyclooxygenase metabolite 12-L-hydroxy-5, 8, 10-hepta-decatrienoic acid (HHT) may modulate primary hemostasis by stimulating prostacyclin production.
    Sadowitz PD; Setty BN; Stuart M
    Prostaglandins; 1987 Nov; 34(5):749-63. PubMed ID: 3124219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions].
    Nunez D; Russo-Marie F; Benveniste J
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of arachidonate metabolism in cardiovascular system by cigarette smoking.
    Tai HH; Chang WC; Liu Y; Fukuda S
    Adv Exp Med Biol; 1990; 273():211-24. PubMed ID: 2126909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of SIN-1 on the oxygenated metabolism of arachidonic acid in blood platelets and endothelial cells].
    Lagarde M; Croset M; Bordet JC
    Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):216-7. PubMed ID: 3550640
    [No Abstract]   [Full Text] [Related]  

  • 20. Toxicological effects of beryllium on platelets and vascular endothelium.
    Togna G; Togna AR; Russo P; Caprino L
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):262-7. PubMed ID: 9194409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.